Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018)
Lemaitre Vascular (LMAT) posted quarterly Non-Current Deffered Revenue of $530000.0 for Q4 2018, down 5.53% year-over-year from $561000.0 in Q4 2017, and down 1.67% quarter-over-quarter from $539000.0 in Q3 2018.
Lemaitre Vascular (LMAT) Non-Current Deffered Revenue (2015 - 2018) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Non-Current Deffered Revenue for 4 consecutive years, with $530000.0 the latest figure, recorded in Q4 2018.
- In Q4 2018, Non-Current Deffered Revenue fell 5.53% year-over-year to $530000.0; the TTM figure through Dec 2018 stood at $530000.0 (down 5.53% YoY), while the FY2018 annual figure was $530000.0, down 5.53% from the prior year.
- Non-Current Deffered Revenue eased to $530000.0 in Q4 2018 per LMAT's latest filing, from $539000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $561000.0 in Q4 2017 and bottomed at $281000.0 in Q4 2015.
- Historically, Non-Current Deffered Revenue has averaged $481400.0 across 4 years, with a median of $532000.0 in 2017.
- Annual changes were most pronounced in 2017 — Non-Current Deffered Revenue soared 42.39% — and 2018, when it retreated 5.53%.
- Lemaitre Vascular's Non-Current Deffered Revenue stood at $281000.0 in 2015, then jumped by 40.21% to $394000.0 in 2016, then surged by 42.39% to $561000.0 in 2017, then slipped by 5.53% to $530000.0 in 2018.
- Business Quant data shows LMAT's Non-Current Deffered Revenue at $530000.0 in Q4 2018, $539000.0 in Q3 2018, and $547000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 530,000.00 |
| Sep 30, 2018 | 539,000.00 |
| Jun 30, 2018 | 547,000.00 |
| Mar 31, 2018 | 554,000.00 |
| Dec 31, 2017 | 561,000.00 |
| Sep 30, 2017 | 534,000.00 |
| Jun 30, 2017 | 452,000.00 |
| Mar 31, 2017 | 422,000.00 |
| Dec 31, 2016 | 394,000.00 |
| Dec 31, 2015 | 281,000.00 |